{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T11:21:18Z","timestamp":1793532078116,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"46","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"crossref","award":["OPP50419"],"award-info":[{"award-number":["OPP50419"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.vaccine.2011.08.108","type":"journal-article","created":{"date-parts":[[2011,9,10]],"date-time":"2011-09-10T13:26:41Z","timestamp":1315661201000},"page":"8285-8292","source":"Crossref","is-referenced-by-count":98,"title":["Safety and immunogenicity study of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine Shanchol, in Bangladeshi adults and children as young as 1 year of age"],"prefix":"10.1016","volume":"29","author":[{"given":"Amit","family":"Saha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohiul Islam","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhana","family":"Khanam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Saruar","family":"Bhuiyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahima","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashraful Islam","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iqbal Ansary","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Clemens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Cravioto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firdausi","family":"Qadri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"June (6)","key":"10.1016\/j.vaccine.2011.08.108_bib0005","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.4269\/ajtmh.2006.74.1067","article-title":"Diarrheal epidemics in Dhaka Bangladesh, during three consecutive floods: 1988, 1998, and 2004","volume":"74","author":"Schwartz","year":"2006","journal-title":"Am J Trop Med Hyg"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.08.108_bib0010","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa1012928","article-title":"The origin of the Haitian cholera outbreak strain","volume":"364","author":"Chin","year":"2011","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.vaccine.2011.08.108_bib0015","doi-asserted-by":"crossref","first-page":"e952","DOI":"10.1371\/journal.pntd.0000952","article-title":"The case for reactive mass oral cholera vaccinations","volume":"5","author":"Reyburn","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2011.08.108_bib0020","unstructured":"WHO. Cholera vaccine. WHO position paper; 2010."},{"key":"10.1016\/j.vaccine.2011.08.108_bib0025","unstructured":"WHO\/PAHO. Haiti. Cholera response update; 2010."},{"issue":"4","key":"10.1016\/j.vaccine.2011.08.108_bib0030","doi-asserted-by":"crossref","first-page":"e221","DOI":"10.1371\/journal.pntd.0000221","article-title":"Susceptibility to Vibrio cholerae infection in a cohort of household contacts of patients with cholera in Bangladesh","volume":"2","author":"Harris","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2011.08.108_bib0035","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1471-2334-5-89","article-title":"The burden of diarrhoea, shigellosis, and cholera in North Jakarta, Indonesia: findings from 24 months surveillance","volume":"5","author":"Agtini","year":"2005","journal-title":"BMC Infect Dis"},{"issue":"November (1)","key":"10.1016\/j.vaccine.2011.08.108_bib0040","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1097\/INF.0b013e3181783adf","article-title":"A comparison of clinical and immunologic features in children and older patients hospitalized with severe cholera in Bangladesh","volume":"27","author":"Chowdhury","year":"2008","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.1016\/j.vaccine.2011.08.108_bib0045","doi-asserted-by":"crossref","first-page":"e173","DOI":"10.1371\/journal.pntd.0000173","article-title":"The high burden of cholera in children: comparison of incidence from endemic areas in Asia and Africa","volume":"2","author":"Deen","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"issue":"December (6)","key":"10.1016\/j.vaccine.2011.08.108_bib0050","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1093\/oxfordjournals.aje.a113498","article-title":"Endemic cholera in rural Bangladesh, 1966\u20131980","volume":"116","author":"Glass","year":"1982","journal-title":"Am J Epidemiol"},{"issue":"February (8684)","key":"10.1016\/j.vaccine.2011.08.108_bib0055","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/0140-6736(90)90080-O","article-title":"Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up","volume":"335","author":"Clemens","year":"1990","journal-title":"Lancet"},{"issue":"November (9702)","key":"10.1016\/j.vaccine.2011.08.108_bib0060","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1016\/S0140-6736(09)61297-6","article-title":"Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial","volume":"374","author":"Sur","year":"2009","journal-title":"Lancet"},{"issue":"January (2)","key":"10.1016\/j.vaccine.2011.08.108_bib0065","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.vaccine.2006.08.031","article-title":"Peru-15, a live attenuated oral cholera vaccine, is safe and immunogenic in Bangladeshi toddlers and infants","volume":"25","author":"Qadri","year":"2007","journal-title":"Vaccine"},{"issue":"August (4)","key":"10.1016\/j.vaccine.2011.08.108_bib0070","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1086\/432074","article-title":"Randomized, controlled study of the safety and immunogenicity of Peru-15, a live attenuated oral vaccine candidate for cholera, in adult volunteers in Bangladesh","volume":"192","author":"Qadri","year":"2005","journal-title":"J Infect Dis"},{"issue":"May (22)","key":"10.1016\/j.vaccine.2011.08.108_bib0075","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1016\/S0264-410X(00)00006-2","article-title":"Efficacy trial of single-dose live oral cholera vaccine CVD 103-HgR in North Jakarta Indonesia, a cholera-endemic area","volume":"18","author":"Richie","year":"2000","journal-title":"Vaccine"},{"issue":"September (8821)","key":"10.1016\/j.vaccine.2011.08.108_bib0080","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/0140-6736(92)92231-4","article-title":"Safety and immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR in 5\u20139-year-old Indonesian children","volume":"340","author":"Suharyono","year":"1992","journal-title":"Lancet"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2011.08.108_bib0085","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1128\/IAI.65.9.3852-3856.1997","article-title":"Evaluation of a bivalent (CVD 103-HgR\/CVD 111) live oral cholera vaccine in adult volunteers from the United States and Peru","volume":"65","author":"Taylor","year":"1997","journal-title":"Infect Immun"},{"issue":"January (6)","key":"10.1016\/j.vaccine.2011.08.108_bib0090","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.vaccine.2006.09.049","article-title":"Safety and immunogenicity of a reformulated Vietnamese bivalent killed, whole-cell, oral cholera vaccine in adults","volume":"25","author":"Anh","year":"2007","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2011.08.108_bib0095","doi-asserted-by":"crossref","first-page":"e2323","DOI":"10.1371\/journal.pone.0002323","article-title":"A randomized, placebo-controlled trial of the bivalent killed, whole-cell, oral cholera vaccine in adults and children in a cholera endemic area in Kolkata, India","volume":"3","author":"Mahalanabis","year":"2008","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.vaccine.2011.08.108_bib0100","doi-asserted-by":"crossref","first-page":"e999","DOI":"10.1371\/journal.pntd.0000999","article-title":"Impact of rapid urbanization on the rates of infection by Vibrio cholerae O1 and enterotoxigenic Escherichia coli in Dhaka, Bangladesh","volume":"5","author":"Chowdhury","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.08.108_bib0105","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/infdis\/155.1.79","article-title":"B subunit-whole cell and whole cell-only oral vaccines against cholera: studies on reactogenicity and immunogenicity","volume":"155","author":"Clemens","year":"1987","journal-title":"J Infect Dis"},{"issue":"March (10)","key":"10.1016\/j.vaccine.2011.08.108_bib0110","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1016\/j.vaccine.2005.08.110","article-title":"doses of oral killed enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine is safe and immunogenic in Bangladeshi infants 6\u201317 months of age: dosing studies in different age groups","volume":"24","author":"Qadri","year":"2006","journal-title":"Vaccine"},{"issue":"February (9)","key":"10.1016\/j.vaccine.2011.08.108_bib0115","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.vaccine.2008.12.041","volume":"27","author":"Shamsuzzaman","year":"2009","journal-title":"Vaccine"},{"issue":"November (6)","key":"10.1016\/j.vaccine.2011.08.108_bib0120","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1128\/CDLI.2.6.685-688.1995","article-title":"Comparison of the vibriocidal antibody response in cholera due to Vibrio cholerae O139 Bengal with the response in cholera due to Vibrio cholerae O1","volume":"2","author":"Qadri","year":"1995","journal-title":"Clin Diagn Lab Immunol"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2011.08.108_bib0125","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1128\/IAI.65.9.3571-3576.1997","article-title":"Comparison of immune responses in patients infected with Vibrio cholerae O139 and O1","volume":"65","author":"Qadri","year":"1997","journal-title":"Infect Immun"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2011.08.108_bib0130","doi-asserted-by":"crossref","first-page":"6577","DOI":"10.1128\/IAI.73.10.6577-6583.2005","article-title":"Reduction in capsular content and enhanced bacterial susceptibility to serum killing of Vibrio cholerae O139 associated with the 2002 cholera epidemic in Bangladesh","volume":"73","author":"Qadri","year":"2005","journal-title":"Infect Immun"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2011.08.108_bib0135","doi-asserted-by":"crossref","first-page":"4808","DOI":"10.1128\/IAI.71.8.4808-4814.2003","article-title":"Antigen- specific immunoglobulin A antibodies secreted from circulating B cells are an effective marker for recent local immune responses in patients with cholera: comparison to antibody-secreting cell responses and other immunological markers","volume":"71","author":"Qadri","year":"2003","journal-title":"Infect Immun"},{"issue":"June (19\u201320)","key":"10.1016\/j.vaccine.2011.08.108_bib0140","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1016\/S0264-410X(03)00077-X","article-title":"Safety and immunogenicity of an oral, inactivated enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine in Bangladeshi children 18\u201336 months of age","volume":"21","author":"Qadri","year":"2003","journal-title":"Vaccine"},{"issue":"November (6)","key":"10.1016\/j.vaccine.2011.08.108_bib0145","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1128\/CDLI.6.6.812-818.1999","article-title":"Lipopolysaccharide- and cholera toxin-specific subclass distribution of B-cell responses in cholera","volume":"6","author":"Qadri","year":"1999","journal-title":"Clin Diagn Lab Immunol"},{"issue":"November (49)","key":"10.1016\/j.vaccine.2011.08.108_bib0150","doi-asserted-by":"crossref","first-page":"6887","DOI":"10.1016\/j.vaccine.2009.09.008","article-title":"Immune responses following one and two doses of the reformulated, bivalent, killed, whole-cell, oral cholera vaccine among adults and children in Kolkata, India: a randomized, placebo-controlled trial","volume":"27","author":"Kanungo","year":"2009","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2011.08.108_bib0155","first-page":"2","article-title":"Investigations into the safety and immunogenicity of a killed oral cholera vaccine developed in Viet Nam","volume":"80","author":"Trach","year":"2002","journal-title":"Bull World Health Organ"},{"issue":"January (9047)","key":"10.1016\/j.vaccine.2011.08.108_bib0160","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0140-6736(96)06107-7","article-title":"Field trial of a locally produced, killed, oral cholera vaccine in Vietnam","volume":"349","author":"Trach","year":"1997","journal-title":"Lancet"},{"issue":"March (6)","key":"10.1016\/j.vaccine.2011.08.108_bib0165","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1086\/368132","article-title":"Supplementation with zinc, but not vitamin A, improves seroconversion to vibriocidal antibody in children given an oral cholera vaccine","volume":"187","author":"Albert","year":"2003","journal-title":"J Infect Dis"},{"issue":"February (10)","key":"10.1016\/j.vaccine.2011.08.108_bib0170","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/j.vaccine.2010.12.133","article-title":"Evaluation of a probiotics Bifidobacterium breve BBG-01, for enhancement of immunogenicity of an oral inactivated cholera vaccine and safety: a randomized, double-blind, placebo-controlled trial in Bangladeshi children under 5 years of age","volume":"29","author":"Matsuda","year":"2011","journal-title":"Vaccine"},{"issue":"August (8609)","key":"10.1016\/j.vaccine.2011.08.108_bib0175","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0140-6736(88)90120-1","article-title":"Safety, immunogenicity, and efficacy of recombinant live oral cholera vaccines, CVD 103 and CVD 103-HgR","volume":"2","author":"Levine","year":"1988","journal-title":"Lancet"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2011.08.108_bib0180","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1128\/CVI.00562-10","article-title":"Antigen-specific memory B-cell responses in Bangladeshi adults after one- or two-dose oral killed cholera vaccination and comparison with responses in patients with naturally acquired cholera","volume":"18","author":"Alam","year":"2011","journal-title":"Clin Vaccine Immunol"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2011.08.108_bib0185","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1093\/infdis\/149.6.884","article-title":"Mucosal antitoxic and antibacterial immunity after cholera disease and after immunization with a combined B subunit-whole cell vaccine","volume":"149","author":"Svennerholm","year":"1984","journal-title":"J Infect Dis"},{"issue":"February (9)","key":"10.1016\/j.vaccine.2011.08.108_bib0190","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/j.vaccine.2008.12.036","article-title":"Enhanced immunogenicity of an oral inactivated cholera vaccine in infants in Bangladesh obtained by zinc supplementation and by temporary withholding breast-feeding","volume":"27","author":"Ahmed","year":"2009","journal-title":"Vaccine"},{"issue":"October (15)","key":"10.1016\/j.vaccine.2011.08.108_bib0195","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/S0264-410X(96)00071-0","article-title":"Intestinal and systemic immune responses in humans after oral immunization with a bivalent B subunit-O1\/O139 whole cell cholera vaccine","volume":"14","author":"Jertborn","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.08.108_bib0200","unstructured":"WHO. Cholera: mechanism for control and prevention. Sixty-fourth World Health Assembly; 2011."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11013855?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11013855?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T14:55:37Z","timestamp":1592924137000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11013855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":40,"journal-issue":{"issue":"46","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0264410X11013855"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.08.108","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}